Green Cross Lab Cell Corporation (144510) — Capital Reinvestment Ratio
Green Cross Lab Cell Corporation (144510) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩6.67 Billion) in capital expenditures (₩624.50 Million). See Green Cross Lab Cell Corporation free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Lab Cell Corporation Capital Reinvestment Ratio (2015–2024)
This chart tracks Green Cross Lab Cell Corporation's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Green Cross Lab Cell Corporation (2015–2024)
Year-by-year Capital Reinvestment Ratio for Green Cross Lab Cell Corporation from 2015 to 2024. For live market cap and broader valuation context, see Green Cross Lab Cell Corporation market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.53x | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.4% |
| 2023 | 5.01x | ₩3.67 Billion | ₩18.40 Billion | ▲ +4713.9% |
| 2022 | 0.10x | ₩66.42 Billion | ₩6.91 Billion | ▼ -77.1% |
| 2021 | 0.45x | ₩23.91 Billion | ₩10.88 Billion | ▼ -13.6% |
| 2020 | 0.53x | ₩9.09 Billion | ₩4.79 Billion | ▼ -97.8% |
| 2019 | 23.96x | ₩223.04 Million | ₩5.34 Billion | ▲ +146.1% |
| 2018 | 9.74x | ₩490.92 Million | ₩4.78 Billion | ▲ +1468.4% |
| 2017 | 0.62x | ₩2.86 Billion | ₩1.78 Billion | ▲ +10.8% |
| 2015 | 0.56x | ₩1.49 Billion | ₩833.86 Million | — |